Olivia T. Preble

2.4k total citations
27 papers, 1.9k citations indexed

About

Olivia T. Preble is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Olivia T. Preble has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Olivia T. Preble's work include Virology and Viral Diseases (6 papers), Animal Virus Infections Studies (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Olivia T. Preble is often cited by papers focused on Virology and Viral Diseases (6 papers), Animal Virus Infections Studies (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Olivia T. Preble collaborates with scholars based in United States, Malaysia and Poland. Olivia T. Preble's co-authors include Julius S. Youngner, Robert M. Friedman, J Vilček, John H. Klippel, Roberta Black, James J. Goedert, M. Elaine Eyster, Joseph Sonnabend, Eugene DeStefano and Dorothy Henriksen and has published in prestigious journals such as Science, New England Journal of Medicine and The Journal of Experimental Medicine.

In The Last Decade

Olivia T. Preble

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia T. Preble United States 20 785 487 389 342 331 27 1.9k
G. B. Clements United Kingdom 25 448 0.6× 738 1.5× 407 1.0× 111 0.3× 53 0.2× 58 2.0k
L. C. Archard United Kingdom 27 232 0.3× 903 1.9× 100 0.3× 504 1.5× 129 0.4× 65 2.8k
S. Haahr Denmark 22 590 0.8× 513 1.1× 414 1.1× 74 0.2× 159 0.5× 59 1.5k
Cecilia Simonelli Italy 24 1.4k 1.8× 517 1.1× 770 2.0× 372 1.1× 187 0.6× 78 3.2k
H. O. Kangro United Kingdom 23 185 0.2× 855 1.8× 340 0.9× 89 0.3× 92 0.3× 47 2.1k
Samantha S. Soldan United States 29 1.2k 1.5× 959 2.0× 741 1.9× 167 0.5× 155 0.5× 62 3.3k
Salvatore Sampognaro Italy 21 2.0k 2.5× 433 0.9× 314 0.8× 183 0.5× 229 0.7× 26 3.1k
Maria Luisa Villa Italy 28 1.8k 2.3× 700 1.4× 329 0.8× 841 2.5× 139 0.4× 73 3.2k
N Balachandran United States 19 324 0.4× 1.5k 3.2× 656 1.7× 134 0.4× 52 0.2× 39 2.0k
Marc S. Horwitz Canada 27 2.0k 2.6× 575 1.2× 273 0.7× 910 2.7× 196 0.6× 81 3.6k

Countries citing papers authored by Olivia T. Preble

Since Specialization
Citations

This map shows the geographic impact of Olivia T. Preble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia T. Preble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia T. Preble more than expected).

Fields of papers citing papers by Olivia T. Preble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia T. Preble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia T. Preble. The network helps show where Olivia T. Preble may publish in the future.

Co-authorship network of co-authors of Olivia T. Preble

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia T. Preble. A scholar is included among the top collaborators of Olivia T. Preble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia T. Preble. Olivia T. Preble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Straus, Stephen E., Janet K. Dale, Martin Tobi, et al.. (1988). Acyclovir Treatment of the Chronic Fatigue Syndrome. New England Journal of Medicine. 319(26). 1692–1698. 164 indexed citations
2.
Orenstein, Jan M., Olivia T. Preble, Phyllis D. Kind, & Richard S. Schulof. (1987). The Relationship of Serum Alpha-Interferon and Ultrastructural Markers in HIV-Seropositive Individuals. Ultrastructural Pathology. 11(5-6). 673–679. 25 indexed citations
3.
Gelmann, Edward P., Dan L. Longo, H. Clifford Lane, et al.. (1987). Combination chemotherapy of disseminated kaposi's sarcoma in patients with the acquired immune deficiency syndrome. The American Journal of Medicine. 82(3). 456–462. 57 indexed citations
4.
Kreiss, Joan K., Lynn W. Kitchen, Harry E. Prince, et al.. (1986). Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study. The American Journal of Medicine. 80(3). 345–350. 25 indexed citations
5.
6.
Carette, Simon, et al.. (1985). Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus.. Annals of the Rheumatic Diseases. 44(2). 104–108. 17 indexed citations
7.
Gelmann, Edward P., Olivia T. Preble, Ronald G. Steis, et al.. (1985). Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. The American Journal of Medicine. 78(5). 737–741. 86 indexed citations
8.
Preble, Olivia T. & E. Fuller Torrey. (1985). Serum interferon in patients with psychosis. American Journal of Psychiatry. 142(10). 1184–1186. 38 indexed citations
9.
Longo, Dan L., Ronald G. Steis, H. Clifford Lane, et al.. (1984). MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS. Annals of the New York Academy of Sciences. 437(1). 421–430. 39 indexed citations
10.
11.
Eyster, M. Elaine, et al.. (1983). Acid-Labile Alpha Interferon. New England Journal of Medicine. 309(10). 583–586. 162 indexed citations
12.
Johnston, Margaret I., Olivia T. Preble, Jiro Imai, Helmut Jacobsen, & Paul F. Torrence. (1983). A sensitive immunoenzymometric assay for 2′,5′-oligoadenylate. Detection of elevated 2′,5′-oligoadenylate synthetase in human peripheral mononuclear cells. Journal of Immunological Methods. 65(1-2). 123–135. 6 indexed citations
13.
DeStefano, Eugene, Robert M. Friedman, Alvin E. Friedman‐Kien, et al.. (1982). Acid-Labile Human Leukocyte Interferon in Homosexual Men with Kaposi's Sarcoma and Lymphadenopathy. The Journal of Infectious Diseases. 146(4). 451–455. 267 indexed citations
14.
Friedman, Robert M., et al.. (1982). Interferon production in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 25(7). 802–803. 12 indexed citations
15.
Preble, Olivia T., Roberta Black, Robert M. Friedman, John H. Klippel, & J Vilček. (1982). Systemic Lupus Erythematosus: Presence in Human Serum of an Unusual Acid-Labile Leukocyte Interferon. Science. 216(4544). 429–431. 370 indexed citations
16.
Preble, Olivia T., et al.. (1980). Neurovirulence Mutant of Vesicular Stomatitis Virus with an Altered Target Cell Tropism In Vivo. Infection and Immunity. 29(2). 744–757. 9 indexed citations
17.
Youngner, Julius S., Olivia T. Preble, & Elaine V. Jones. (1978). Persistent Infection of L Cells with Vesicular Stomatitis Virus: Evolution of Virus Populations. Journal of Virology. 28(1). 6–13. 34 indexed citations
18.
Youngner, Julius S., et al.. (1976). Role of temperature-sensitive mutants in persistent infections initiated with vesicular stomatitis virus. Journal of Virology. 19(1). 90–101. 77 indexed citations
19.
Preble, Olivia T. & Julius S. Youngner. (1973). Selection of Temperature-Sensitive Mutants During Persistent Infection: Role in Maintenance of Persistent Newcastle Disease Virus Infections of L Cells. Journal of Virology. 12(3). 481–491. 48 indexed citations
20.
Preble, Olivia T. & Julius S. Youngner. (1973). Temperature-Sensitive Defect of Mutants Isolated from L Cells Persistently Infected with Newcastle Disease Virus. Journal of Virology. 12(3). 472–480. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. B. Clements Breakdown of academic impact, for papers by L. C. Archard Breakdown of academic impact, for papers by S. Haahr Breakdown of academic impact, for papers by Cecilia Simonelli Breakdown of academic impact, for papers by H. O. Kangro Breakdown of academic impact, for papers by Samantha S. Soldan Breakdown of academic impact, for papers by Salvatore Sampognaro Breakdown of academic impact, for papers by Maria Luisa Villa Breakdown of academic impact, for papers by N Balachandran Breakdown of academic impact, for papers by Marc S. Horwitz
Rankless by CCL
2026